Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
2012;8:e1002708
The data indicated that when the follow-up was 19.4 months, patients in the bevacizumab group had a longer median PFS (restricted mean) than that of the standard-therapy group (21.8 months vs
Brenner Labs
HjelmsMHMollerupSJensenRHPietroniCLukjancenkoOSchultzACet alMetagenomic analysis of viruses in toilet waste from long distance flightsa new procedure for global infectious disease surveillance
US$ 26.72
US$ 27.93
US$ 20.48
US$ 21.81
US$ 26.75
US$ 23.83
